The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(1H-tetrazol-5-yl)phenyl)-2-(benzo[d]oxazol-2-ylamino)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyrimidine-5-carboxamide ID: ALA5076940
PubChem CID: 166626169
Max Phase: Preclinical
Molecular Formula: C27H21ClN8O2
Molecular Weight: 524.97
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC1=C(C(=O)Nc2ccc(-c3nnc[nH]3)cc2)C(c2ccccc2Cl)N=C(Nc2nc3ccccc3o2)N1
Standard InChI: InChI=1S/C27H21ClN8O2/c1-15-22(25(37)32-17-12-10-16(11-13-17)24-29-14-30-36-24)23(18-6-2-3-7-19(18)28)34-26(31-15)35-27-33-20-8-4-5-9-21(20)38-27/h2-14,23H,1H3,(H,32,37)(H,29,30,36)(H2,31,33,34,35)
Standard InChI Key: OSFNRQRXYYNBSJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
39.9547 -11.3112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6224 -12.2382 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.9246 -13.1849 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.8143 -12.8362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8143 -11.6659 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.8008 -13.4213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8030 -14.5858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7934 -15.1764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7756 -14.5886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7760 -13.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7871 -12.8359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7621 -15.1737 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.7487 -14.5885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7487 -13.4183 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.7352 -15.1737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7352 -16.3439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7486 -16.9290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7217 -16.9290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.7082 -16.3439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6947 -16.9291 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.6812 -16.3439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5590 -15.1807 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.4148 -14.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8271 -13.9204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6582 -13.9204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0786 -14.9367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6639 -15.9505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8299 -15.9505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6127 -16.8197 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.7082 -15.1737 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.7217 -14.5886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7217 -13.4183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7287 -12.8343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7287 -11.6640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7192 -11.0799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7058 -11.6646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7058 -12.8395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6923 -13.4247 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
3 2 1 0
4 3 2 0
4 5 1 0
5 1 1 0
4 6 1 0
7 6 1 0
8 7 2 0
9 8 1 0
10 9 2 0
11 10 1 0
6 11 2 0
9 12 1 0
13 12 1 0
13 14 2 0
15 13 1 0
16 15 2 0
16 17 1 0
18 16 1 0
19 18 1 0
19 20 1 0
20 21 1 0
22 21 2 0
23 22 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
28 27 1 0
29 28 1 0
29 21 1 0
28 23 2 0
30 19 2 0
30 31 1 0
31 15 1 0
31 32 1 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 37 1 0
37 38 1 0
37 32 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 524.97Molecular Weight (Monoisotopic): 524.1476AlogP: 5.29#Rotatable Bonds: 5Polar Surface Area: 133.12Molecular Species: NEUTRALHBA: 8HBD: 4#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 9.99CX Basic pKa: 3.49CX LogP: 3.88CX LogD: 3.88Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.25Np Likeness Score: -1.26
References 1. (2021) Galactokinase inhibitors,